Cardiff Oncology, Inc. (CRDF)
USD 2.81
(-0.18%)
USD 2.81
(-0.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -30.88 Million | -33.82 Million | -23.04 Million | -16.31 Million | -13.26 Million | -13.2 Million |
| Net Income | -41.44 Million | -38.7 Million | -28.29 Million | -19.3 Million | -16.41 Million | -16.46 Million |
| Depreciation & Amortization | 398 Thousand | 236 Thousand | 451 Thousand | 466 Thousand | 494 Thousand | 859 Thousand |
| Deferred income taxes | -3.31 Million | - | 1.32 Million | 315.01 Thousand | -28 Thousand | -635 Thousand |
| Stock-based compensation | 4.5 Million | 4.25 Million | 3.23 Million | 1.76 Million | 885 Thousand | 2.17 Million |
| Change in working capital | 6.56 Million | -380 Thousand | -1.78 Million | -654.53 Thousand | 1.09 Million | 98 Thousand |
| Other non-cash items | 2.39 Million | 772 Thousand | 2.03 Million | 1.1 Million | 703 Thousand | 764 Thousand |
| Investing Cash Flow | 36.19 Million | 38.14 Million | -131.44 Million | -211.88 Thousand | -68 Thousand | 23 Thousand |
| Investments in PPE | -582 Thousand | -892 Thousand | -205 Thousand | -211.88 Thousand | -68 Thousand | -5100.00 |
| Acquisitions | -36.77 Million | -114 Thousand | 205 Thousand | - | - | 5100.00 |
| Investment purchases | -70.08 Million | -91.23 Million | -174.38 Million | - | - | -31.5 Thousand |
| Sales/Maturities of investments | 106.86 Million | 130.27 Million | 43.14 Million | - | - | 31.5 Thousand |
| Other Investing Activities | 36.77 Million | 114 Thousand | -205 Thousand | - | - | 23 Thousand |
| Financing Cash Flow | - | 75 Thousand | 35.45 Million | 137.31 Million | 12.07 Million | 16.4 Million |
| Debt repayment | - | - | - | -305 Thousand | - | -1.37 Million |
| Dividends payments | - | -414 Thousand | -24 Thousand | -24.24 Million | -24.24 Million | -24.24 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 75 Thousand | 34.18 Million | 137.31 Million | 8.81 Million | 17.77 Million |
| Other Financing Activities | - | 414 Thousand | 1.28 Million | 137.31 Million | 27.5 Million | 17.77 Million |
| Accounts receivables | 483 Thousand | -236 Thousand | -215 Thousand | -116.97 Million | -35.72 Million | 19.26 Million |
| Accounts payables | 2.83 Million | 1.34 Million | 719 Thousand | 1.27 Billion | 1.45 Billion | 236.48 Million |
| Inventory | - | - | - | -1.15 Billion | -1.41 Billion | -255.62 Million |
| Other working capital | 3.25 Million | -1.49 Million | -2.29 Million | -654.53 Thousand | 1.09 Million | -23.75 Thousand |
| Cash at beginning of period | 16.34 Million | 11.94 Million | 130.98 Million | 10.19 Million | 11.45 Million | 8.22 Million |
| Cash at end of period | 21.65 Million | 16.34 Million | 11.94 Million | 130.98 Million | 10.19 Million | 11.45 Million |
| Capital Expenditure | -582 Thousand | -892 Thousand | -205 Thousand | -211.88 Thousand | -68 Thousand | -5100.00 |
| Effect of forex changes on cash | - | - | - | - | - | 369.00 |
| Net cash flow / Change in cash | 5.3 Million | 4.4 Million | -119.03 Million | 120.78 Million | -1.25 Million | 3.22 Million |
| Free Cash Flow | -31.46 Million | -34.71 Million | -23.24 Million | -16.52 Million | -13.33 Million | -13.2 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -11.77 Million | -10.01 Million | -41.44 Million | -9.33 Million | -9.73 Million | -11.15 Million |
| Depreciation & Amortization | 105 Thousand | 102 Thousand | 398 Thousand | 103 Thousand | 107 Thousand | 98 Thousand |
| Deferred income taxes | - | - | -3.31 Million | 21.43 Million | -10.04 Million | -11.39 Million |
| Stock-based compensation | 1.17 Million | 1.12 Million | 4.5 Million | 909 Thousand | 955 Thousand | 1.58 Million |
| Change in working capital | 1.39 Million | 1.2 Million | 6.56 Million | 1.39 Million | 1.02 Million | 2.58 Million |
| Other non-cash items | 647 Thousand | -138 Thousand | 2.39 Million | -21.63 Million | 9.73 Million | 11.15 Million |
| Investing Cash Flow | 14.01 Million | 4.63 Million | 36.19 Million | 13.56 Million | 3.82 Million | 11.48 Million |
| Investments in PPE | - | -80 Thousand | -582 Thousand | -8000.00 | -315 Thousand | -251 Thousand |
| Acquisitions | - | - | -36.77 Million | 6.77 Million | 315 Thousand | 251 Thousand |
| Investment purchases | - | -919 Thousand | -70.08 Million | -2.59 Million | -16.62 Million | -13.54 Million |
| Sales/Maturities of investments | 14.01 Million | 5.63 Million | 106.86 Million | 16.16 Million | 20.75 Million | 25.27 Million |
| Other Investing Activities | 14.01 Million | 4.71 Million | 36.77 Million | -6.77 Million | -315 Thousand | -251 Thousand |
| Financing Cash Flow | 2.05 Million | 107 Thousand | - | 12 Thousand | -6000.00 | -6000.00 |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -6000.00 | - | - | -12 Thousand | -6000.00 | -6000.00 |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.05 Million | 107 Thousand | - | - | - | - |
| Other Financing Activities | 2.05 Million | 107 Thousand | - | 24 Thousand | 6000.00 | 6000.00 |
| Accounts receivables | -58 Thousand | -105 Thousand | 483 Thousand | -90 Thousand | -37 Thousand | 515 Thousand |
| Accounts payables | 673 Thousand | 1.41 Million | 2.83 Million | 1.4 Million | 135 Thousand | 1.09 Million |
| Inventory | - | - | - | -3.31 Million | - | - |
| Other working capital | 776 Thousand | -109 Thousand | 3.25 Million | 3.39 Million | 925 Thousand | 976 Thousand |
| Cash at beginning of period | 18.65 Million | 21.65 Million | 16.34 Million | 15.23 Million | 19.36 Million | 15.01 Million |
| Cash at end of period | 25.5 Million | 18.65 Million | 21.65 Million | 21.65 Million | 15.23 Million | 19.36 Million |
| Capital Expenditure | - | -80 Thousand | -582 Thousand | -8000.00 | -315 Thousand | -251 Thousand |
| Effect of forex changes on cash | - | - | - | 21.09 Million | -5.59 Million | -15.5 Million |
| Net cash flow / Change in cash | 6.84 Million | -2.99 Million | 5.3 Million | 6.42 Million | -4.13 Million | 4.35 Million |
| Free Cash Flow | -9.23 Million | -7.82 Million | -31.46 Million | -7.14 Million | -8.27 Million | -7.38 Million |
ALLE
6331
HOTLSILV
FCCTP
VEERENRGY
9064